Thrive Wealth Management, LLC Astrazeneca PLC Transaction History
Thrive Wealth Management, LLC
- $609 Million
- Q2 2025
A detailed history of Thrive Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Thrive Wealth Management, LLC holds 4,047 shares of AZN stock, worth $299,761. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,047
Previous 4,135
2.13%
Holding current value
$299,761
Previous $303,000
6.93%
% of portfolio
0.05%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
509MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.23 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.05 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.32 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...